Source: https://www.cambridge.org/core/journals/advances-in-psychiatric-treatment/article/downs-syndrome-and-dementia/D196C809014749FDDFAC6ADAF97DA938
Timestamp: 2019-04-21 16:47:49+00:00

Document:
Galzitskaya, O. V. Galushko, E. I. and Selivanova, O. M. 2018. Studies of the Process of Amyloid Formation by Aβ Peptide. Biochemistry (Moscow), Vol. 83, Issue. S1, p. S62.
Isaev, Nickolay K. Genrikhs, Elisaveta E. Oborina, Maria V. and Stelmashook, Elena V. 2018. Accelerated aging and aging process in the brain. Reviews in the Neurosciences, Vol. 29, Issue. 3, p. 233.
Jozsvai, Emoke Hewitt, Spencer and Gedye, Angela 2018. Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities. p. 57.
Boyd, Kerry and Baril, Veronique 2018. Geriatric Psychiatry. p. 577.
Hategan, Ana Bourgeois, James A. Cheng, Tracy and Young, Julie 2018. Geriatric Psychiatry Study Guide. p. 333.
Rofail, Diana Froggatt, Daniel de la Torre, Rafael Edgin, Jamie Kishnani, Priya Touraine, Renaud Whitwham, Sarah Squassante, Lisa Khwaja, Omar and D’Ardhuy, Xavier Liogier 2017. Health-Related Quality of Life in Individuals with Down Syndrome: Results from a Non-Interventional Longitudinal Multi-National Study. Advances in Therapy, Vol. 34, Issue. 8, p. 2058.
Lautarescu, Bianca Alexandra Holland, Anthony John and Zaman, Shahid H. 2017. The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies. Neuropsychology Review, Vol. 27, Issue. 1, p. 31.
Elliott-King, Jordan Shaw, Sarah Bandelow, Stephan Devshi, Rajal Kassam, Shelina and Hogervorst, Eef 2016. A critical literature review of the effectiveness of various instruments in the diagnosis of dementia in adults with intellectual disabilities. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 4, Issue. , p. 126.
Rowe, Michelle 2016. Will General Practitioners be adequately prepared to meet the complexities of enhanced dementia screening for people with learning disabilities and Down syndrome: key considerations. British Journal of Learning Disabilities, Vol. 44, Issue. 1, p. 43.
Belichenko, Pavel V. Madani, Rime Rey-Bellet, Lorianne Pihlgren, Maria Becker, Ann Plassard, Adeline Vuillermot, Stephanie Giriens, Valérie Nosheny, Rachel L. Kleschevnikov, Alexander M. Valletta, Janice S. Bengtsson, Sara K. S. Linke, Gordon R. Maloney, Michael T. Hickman, David T. Reis, Pedro Granet, Anne Mlaki, Dorin Lopez-Deber, Maria Pilar Do, Long Singhal, Nishant Masliah, Eliezer Pearn, Matthew L. Pfeifer, Andrea Muhs, Andreas Mobley, William C. and Herault, Yann 2016. An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome. PLOS ONE, Vol. 11, Issue. 3, p. e0152471.
Werner, Perla Savva, George M. Maidment, Ian Thyrian, Jochen René and Fox, Chris 2016. Mental Health and Older People. p. 197.
Bajic, Vladan Spremo-Potparevic, Biljana Zivkovic, Lada Isenovic, Esma R. and Arendt, Thomas 2015. Cohesion and the aneuploid phenotype in Alzheimer's disease: A tale of genome instability. Neuroscience & Biobehavioral Reviews, Vol. 55, Issue. , p. 365.
Vicari, Stefano Pontillo, Maria and Armando, Marco 2013. Neurodevelopmental and psychiatric issues in Down’s syndrome. Psychiatric Genetics, Vol. 23, Issue. 3, p. 95.
Maltsev, A. V. Dovidchenko, N. V. Uteshev, V. K. Sokolik, V. V. Shtang, O. M. Yakushin, M. A. Sokolova, N. M. Surin, A. K. and Galzitskaya, O. V. 2013. Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer’s disease. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, Vol. 7, Issue. 4, p. 278.
Krinsky-McHale, Sharon J. and Silverman, Wayne 2013. Dementia and mild cognitive impairment in adults with intellectual disability: Issues of diagnosis. Developmental Disabilities Research Reviews, Vol. 18, Issue. 1, p. 31.
Ruparelia, Aarti Pearn, Matthew L. and Mobley, William C. 2013. Aging and intellectual disability: Insights from mouse models of down syndrome. Developmental Disabilities Research Reviews, Vol. 18, Issue. 1, p. 43.
Jokinen, Nancy Janicki, Matthew P. Keller, Seth M. McCallion, Philip and Force, Lawrence T. 2013. Guidelines for Structuring Community Care and Supports for People With Intellectual Disabilities Affected by Dementia. Journal of Policy and Practice in Intellectual Disabilities, Vol. 10, Issue. 1, p. 1.
Sullivan, Victoria Majumdar, Biswadeep Richman, Anna and Vinjamuri, Sobhan 2012. To scan or not to scan: neuroimaging in mild cognitive impairment and dementia. Advances in Psychiatric Treatment, Vol. 18, Issue. 6, p. 457.
Down's syndrome is the most common genetic disorder seen in clinical practice: about 94% occurs because of non-disjunction of chromosome 21 and 3–5% because of translocation. Individuals increasingly survive to middle and old age, probably because of advances in medical treatment and improved living conditions. People with Down's syndrome have an increased risk of developing Alzheimer's disease in middle age. Within ICD–10 and DSM–IV classifications there is no consensus on the diagnosis of dementia in people with learning disability. New treatments have been licensed for use in mild to moderate Alzheimer's disease (e.g. acetylcholinesterase inhibitors and memantine). The comorbid picture of Down's syndrome and Alzheimer's disease presents a unique challenge to the clinician in both diagnosis and management.
Albert, M. & Cohen, C. (1992) The test for severe impairment: an instrument for the assessment of patients with severe cognitive dysfunction. Journal of the American Geriatric Society, 40, 449–453.
Aylward, E. H., Burt, D. B., Thorpe, L. U. et al (1997) Diagnosis of dementia in individuals with intellectual disability. Journal of Intellectual Disability Research, 41, 152–164.
Aylward, E. H., Li, Q., Honeycutt, N. A. et al (1999) MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. American Journal of Psychiatry, 156, 564–568.
Bouman, W. P. & Pinner, G. (2002) Use of atypical antipsychotic drugs in old age psychiatry. Advances in Psychiatric Treatment, 8, 49–58.
Burt, D. B. & Aylward, E. H. (2000) Test battery for the diagnosis of dementia in individuals with intellectual disability. Journal of Intellectual Disability Research, 44, 175–180.
Cooper, S. A. & Prasher, V. P. (1998) Maladaptive behaviours and symptoms of dementia in adults with Down's syndrome compared with adults with intellectual disabilities of other aetiologies. Journal of Intellectual Disability Research, 42, 293–300.
Cosgrave, M. P., Tyrrell, J., McCarron, M. et al (2000) A five year follow-up study of dementia in persons with Down's syndrome: early symptoms and patterns of deterioration. Irish Journal of Psychological Medicine, 17, 5–11.
Evenhuis, H. M. (1990) The natural history of dementia in Down's syndrome. Archives of Neurology, 47, 263–267.
Evenhuis, H. M. (1996) Further evaluation of the Dementia Questionnaire for Persons with Mental Retardation (DMR). Journal of Intellectual Disability Research, 40, 369–373.
Fraser, B. (1999) Psychopharmacology and people with learning disability. Advances in Psychiatric Treatment, 5, 471–477.
Gedye, A. (1995) Dementia Scale for Down's Syndrome. Manual. Vancouver, BC: Gedye Research and Consulting.
Hemingway-Eltomey, J. M. & Lerner, A. J. (1999) Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome. American Journal of Psychiatry, 156, 1470.
Holland, A. J., Hon, J., Huppert, F. A. et al (1998) Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome. British Journal of Psychiatry, 172, 493–498.
Holland, A. J., Hon, J., Huppert, A. et al (2000) Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. Journal of Intellectual Disability Research, 44, 138–146.
Kishnani, P. S., Spiridigliozzi, G. A., Heller, J. H. et al (2001) Donepezil for Down's syndrome (comment). American Journal of Psychiatry, 158, 143.
Lawlor, B. A., McCarron, M., Wilson, G. et al (2001) Temporal lobe-oriented CT scanning and dementia in Down's syndrome. International Journal of Geriatric Psychiatry, 16, 427–429.
Mann, D. M., Iwatsubo, T., Ihara, Y. et al (1996) Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral haemorrhage associated with mutations in the APP gene. American Journal of Pathology, 148, 1257–1266.
Moss, M. B., Albert, M. S., Butters, N. et al (1986) Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Archives of Neurology, 43, 239–246.
Oliver, C., Crayton, L., Holland, A. et al (1998) A four year prospective study of age-related cognitive change in adults with Down's syndrome. Psychological Medicine, 28, 1365–1377.
Prasher, V. P., Huxley, A. & Haque, M. S. (2002) A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease. Pilot study. International Journal of Geriatric Psychiatry, 17, 270–278.
Rabe, A., Wisniewski, K. E., Schupf, N. et al (1990) Relationship of Down's syndrome to Alzheimer's disease. In Application of Basic Neuroscience to Child Psychiatry (eds Deutsch, S. I., Weizman, A. & Weizman, R.) pp. 325–340. New York: Plenum Press.
Reiss, S., Levitan, G. W. & Szyszko, J. (1982) Emotional disturbance and mental retardation: diagnostic overshadowing. American Journal of Mental Deficiency, 86, 567–574.
Royal College of Psychiatrists (2001) DC–LD [Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation] (Occasional Paper OP48). London: Gaskell.
Schupf, N. (2002) Genetic and host factors for dementia in Down's syndrome. British Journal of Psychiatry, 180, 405–410.
Schupf, N., Kapell, D., Nightingale, B. et al (2001) Specificity of the fivefold increase in Alzheimer's disease in mothers of adults with Down syndrome. Neurology, 57, 979–984.
Seltzer, G. B., Schupf, N. & Wu, H. S. (2001) A prospective study of menopause in women with Down syndrome. Journal of Intellectual Disability Research, 45, 1–7.
Simard, M. & Van Reekum, R. (2001) Dementia with Lewy bodies in Down's syndrome. International Journal of Geriatric Psychiatry, 16, 311–320.
Temple, V., Jozsvai, E., Konstantareas, M. M. et al (2001) Alzheimer dementia in Down's syndrome: the relevance of cognitive ability. Journal of Intellectual Disability Research, 45, 47–55.
Tyrell, J., Cosgrave, M., McCarron, M. et al (2001) Dementia in people with Down's syndrome. International Journal of Geriatric Psychiatry, 16, 1168–1174.
Visser, F. E., Aldenkamp, A. P., Van Huffelen, A. C. et al (1997) Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. American Journal on Mental Retardation, 101, 400–412.
Wisniewski, K. E., Wisniewski, H. M. & Wen, G. Y. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Annals of Neurology, 17, 278–282.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.